Form 4 for MED MEDIFAST INC
Accepted 2023-05-01 00:00:00 ET · period of report 2023-02-24 · accession 0001628280-23-014348 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-05-01 | 2023-02-24+ | MED | Chard Daniel R | COB, CEO, Dir | A - Grant | $0.00 | +50.9K | 47.1K | New | $0 |
| M | 2023-05-01 | 2023-02-24+ | MED | Chard Daniel R | COB, CEO, Dir | F - Tax | $109.22 | -17.9K | 32.6K | -35% | -$1.95M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-24 | A | A | 34,076 | $0.00 | 48,194 | D | — | — | (F1) 17,038 Performance Stock Units were granted on February 19, 2020, and vested on December 31, 2022 and converted into common stock on a two-for-one basis due to the achievement of certain performance factors. The Compensation Committee of the Medifast Board of Directors approved the performance factors on February 24, 2023 and the shares were released on March 7, 2023. |
| 2 | Common | Common Stock | 2023-03-17 | A | A | 16,807 | $0.00 | 47,128 | D | — | — | (F2) Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| 3 | Common | Common Stock | 2023-03-17 | F | D | 872 | $102.75 | 30,321 | D | — | — | |
| 4 | Common | Common Stock | 2023-03-16 | F | D | 1,358 | $104.46 | 31,193 | D | — | — | |
| 5 | Common | Common Stock | 2023-02-24 | F | D | 15,643 | $109.99 | 32,551 | D | — | — | (F1) 17,038 Performance Stock Units were granted on February 19, 2020, and vested on December 31, 2022 and converted into common stock on a two-for-one basis due to the achievement of certain performance factors. The Compensation Committee of the Medifast Board of Directors approved the performance factors on February 24, 2023 and the shares were released on March 7, 2023. |